IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 225 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,236,086 | +11.2% | 50,805 | -2.1% | 0.01% | +60.0% |
| Q4 2022 | $1,111,179 | +17.1% | 51,900 | -1.8% | 0.01% | -16.7% |
| Q3 2022 | $949,000 | +96.9% | 52,871 | +5.6% | 0.01% | -14.3% |
| Q2 2022 | $482,000 | -92.7% | 50,078 | -87.2% | 0.01% | -91.2% |
| Q1 2022 | $6,575,000 | +2616.9% | 390,693 | +1287.3% | 0.08% | +3900.0% |
| Q4 2019 | $242,000 | – | 28,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |